Status:
COMPLETED
SABINA INTERNATIONAL
Lead Sponsor:
AstraZeneca
Conditions:
Asthma
Eligibility:
All Genders
Brief Summary
The aim of the study is to describe the prescribing pattern of the different types of medications which are used to treat asthma, across multiple countries.
Eligibility Criteria
Inclusion
- Male and female patients ≥12 years-old
- Documented diagnosis with Asthma as per medical records.
- Have had ≥3 consultations with the HCP at study start date
- After full explanation, a patient or legal guardian must have signed an informed consent document indicating that they understand the purpose of and the procedures required for the study and are willing to participate in the study.
Exclusion
- Patient with a diagnosis of chronic obstructive pulmonary disease or other chronic respiratory disease different from Asthma.
- An acute or chronic condition that, in the investigator's opinion, would limit the patient's ability to participate in this study
Key Trial Info
Start Date :
March 29 2019
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
May 6 2020
Estimated Enrollment :
8617 Patients enrolled
Trial Details
Trial ID
NCT03857178
Start Date
March 29 2019
End Date
May 6 2020
Last Update
February 11 2021
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Research Site
San Salvador, Argentina